1. Home
  2. IMTX vs MMI Comparison

IMTX vs MMI Comparison

Compare IMTX & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immatics N.V.

IMTX

Immatics N.V.

N/A

Current Price

$6.32

Market Cap

992.8M

Sector

Health Care

ML Signal

N/A

MMI

Marcus & Millichap Inc.

N/A

Current Price

$23.84

Market Cap

935.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
IMTX
MMI
Founded
N/A
1971
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
992.8M
935.9M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
IMTX
MMI
Price
$6.32
$23.84
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
★ $15.97
N/A
AVG Volume (30 Days)
★ 1.0M
155.6K
Earning Date
11-10-2026
11-06-2026
Dividend Yield
N/A
★ 2.08%
EPS Growth
N/A
★ 84.38
EPS
N/A
★ 0.05
Revenue
N/A
★ $719,700,000.00
Revenue This Year
N/A
$10.59
Revenue Next Year
$14.22
$9.71
P/E Ratio
★ N/A
$480.20
Revenue Growth
N/A
N/A
52 Week Low
$6.06
$23.99
52 Week High
$12.41
$33.55

Technical Indicators

Market Signals
Indicator
IMTX
MMI
Relative Strength Index (RSI) 36.00 28.91
Support Level N/A N/A
Resistance Level $7.95 $31.08
Average True Range (ATR) 0.47 1.03
MACD -0.01 -0.33
Stochastic Oscillator 19.81 0.61

Price Performance

Historical Comparison
IMTX
MMI

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

About MMI Marcus & Millichap Inc.

Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans. The Company has one reportable segment: commercial real estate services. The commercial real estate services segment is the aggregation of our two operating segments: investment sales and financing services.

Share on Social Networks: